Monday, July 25, 2011

Teva's Copaxone challenged

Mylan Inc. and Momenta Pharmaceuticals Inc. have each challenged Teva's patents on Copaxone.

Separately, note the post
Generic drugs have slower approval route than new ones, backlogged by FDA staff shortage

0 Comments:

Post a Comment

<< Home